Literature DB >> 404374

Properties of IgA myeloma proteins isolated rom sera of patients with the hyperviscosity syndrome.

J Mestecky, W J Hammack, R Kulhavy, G P Wright, M Tomana.   

Abstract

Sera, purified myeloma proteins, and urinary proteins obtained from eight patients with igA multiple myeloma were studied by physical-chemical and immunochemical methods. In six patients whose serum viscosity was increased, the sedimentation constants of the principal component of myeloma proteins ranged from 9.1 to 10.2 S. In two patients with nearly normal serum viscosity, the sedimentation constants of these proteins were 6.2 and 7.2 S. IGA-albumin complexes were detected in most of the sera, but invarying amounts; no complexes of ig with amylase, secretory component, or alpha(1)-antitrypsin were observed. Studies on isolated myeloma proteins revealed that all igA proteisn from sera with increased viscosity represented true polymers, linked by disulfide bonds, rather than noncovalently associated aggregates; J chain was detecable by both alkaline-urea disc electrophoresis and immunoelectrophoresis with a monospecific anti-J chain serum. Increased serum viscosity was not related to the igA subclass, L chain type, or the carbohydrate compositions of individual igA myeloma proteins. The urine of five patients contained free light chains corresponding in type to the light chain of the particular igA myeloma protein. However, free J chain was not detected. The immunoelectrophoretic analysis for the presence of J chain in sera of myeloma patients may be used for early and simple detection of polymeric forms of myeloma proteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404374

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  17 in total

1.  Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin.

Authors:  A E Wold; J Mestecky; M Tomana; A Kobata; H Ohbayashi; T Endo; C S Edén
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.

Authors:  J Biewenga; A Faber; J C Pronk; J J Haaijman
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  IgA subclasses of human colostral antibodies specific for microbial and food antigens.

Authors:  I Ladjeva; J H Peterman; J Mestecky
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

4.  Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.

Authors:  G D Barr; M J Hudson; J D Priddle; D P Jewell
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

Review 5.  Plasmapheresis in paraproteinemia.

Authors:  H H Euler; N Schmitz; H Löffler
Journal:  Blut       Date:  1985-06

6.  Quantitative screening of clinical isolates for immunoglobulin A protease production.

Authors:  L E Lindler; F J Stutzenberger
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

7.  Relationship between serum viscosity and intravascular IgA polymer concentration in IgA myeloma.

Authors:  K G Chandy; R A Stockley; R C Leonard; R A Crockson; D Burnett; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

8.  Local production of IgA- and IgM-rheumatoid factors in adult periodontal disease.

Authors:  H Z Hirsch; A Tarkowski; W J Koopman; J Mestecky
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

9.  Factors affecting IgA related hyperviscosity.

Authors:  U Alkner; U B Hansson; F D Lindström
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

10.  Antigenic heterogeneity of immunoglobulin A1 proteases from encapsulated and non-encapsulated Haemophilus influenzae.

Authors:  M Kilian; B Thomsen
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.